Delivery Order SPE2DR25D1202-SPE2DR26F73BN
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,476.17 for TNKASE 50 MG kits on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,334.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TNKASE 50 MG Kits with an ultimate completion date of September 2, 2025. This competitive award, issued on August 29, 2025, carries no set-aside designation and represents a child contract under the prime vendor framework. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $20,678.65 to AmerisourceBergen Drug Corp for TNKASE 50 mg kits on May 26, 2025, with an ultimate completion date of May 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $9,773.14 to AmerisourceBergen Drug Corp for TNKASE 50 mg kits, with performance in Conshohocken, Pennsylvania and an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $23,442.88 to AmerisourceBergen Drug Corp for TNKASE 50 MG kits on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $30,570.33 to AmerisourceBergen Drug Corp for TNKASE 50 MG kits under a firm fixed-price contract. This non-set-aside award was executed on September 18, 2025, with an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,773.14 to supply 50 mg TNKASE kits to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The award, issued on October 31, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of November 3, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,650.80 firm fixed price contract is for the supply of 4566098796 TNKASE 50 MG KITS, with a completion date of October 15, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of...
- This is a $28,268.46 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4565924196 TNKASE 50 MG KITS. The delivery order has a completion date of September 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,327.64, is for the delivery of 4565320280 TNKASE 50 MG KITS and has an ultimate completion date of August 2, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73BNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,579.68 to AmerisourceBergen Drug Corp for TNKASE 50 MG kits on December 15, 2025, with an ultimate completion date of December 16, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is delivering these medical supply kits as part of its federal medical procurement portfolio serving military and veteran healthcare systems. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026. Through this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. The contract demonstrates the contractor's capability to fulfill federal medical supply requirements through competitive procurement processes across multiple therapeutic domains and healthcare entities, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 12/14/25 |